IRadimed Corporation
IRMD
$97.03
$0.770.80%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.03% | 3.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.03% | 3.88% | |||
| Cost of Revenue | 20.23% | 5.69% | |||
| Gross Profit | 3.26% | 3.38% | |||
| SG&A Expenses | 1.97% | 8.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.56% | 5.48% | |||
| Operating Income | 3.80% | 0.67% | |||
| Income Before Tax | 6.75% | -0.40% | |||
| Income Tax Expenses | -21.64% | 10.80% | |||
| Earnings from Continuing Operations | 15.52% | -3.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.52% | -3.42% | |||
| EBIT | 3.80% | 0.67% | |||
| EBITDA | 3.56% | 3.17% | |||
| EPS Basic | 15.35% | -3.46% | |||
| Normalized Basic EPS | 3.82% | -0.42% | |||
| EPS Diluted | 16.35% | -4.44% | |||
| Normalized Diluted EPS | 3.83% | -0.59% | |||
| Average Basic Shares Outstanding | 0.14% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.19% | |||
| Dividend Per Share | 17.65% | 0.00% | |||
| Payout Ratio | 2.42% | 0.04% | |||